Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 18, 2023

SELL
$131.14 - $157.47 $1,442 - $1,732
-11 Reduced 68.75%
5 $0
Q2 2022

Jul 12, 2022

SELL
$155.97 - $200.09 $9,514 - $12,205
-61 Reduced 79.22%
16 $3,000
Q3 2021

Oct 26, 2021

BUY
$189.29 - $209.69 $14,575 - $16,146
77 New
77 $15,000
Q1 2019

Apr 17, 2019

SELL
$81.56 - $100.67 $5,301 - $6,543
-65 Closed
0 $0
Q2 2018

Aug 10, 2018

BUY
$79.9 - $89.2 $1,757 - $1,962
22 Added 51.16%
65 $6,000
Q1 2018

May 08, 2018

SELL
$71.51 - $84.69 $3,074 - $3,641
-43 Reduced 50.0%
43 $4,000
Q4 2017

Jan 11, 2018

SELL
$63.24 - $72.8 $2,276 - $2,620
-36 Reduced 29.51%
86 $6,000
Q3 2017

Oct 31, 2017

BUY
$59.73 - $65.4 $7,287 - $7,978
122
122 $8,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Country Trust Bank Portfolio

Follow Country Trust Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Country Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Country Trust Bank with notifications on news.